PpAzoR, an FMN-dependent NADPH azoreductase from Pseudomonas putida MET94, has been crystallized using the sitting-drop vapour-diffusion technique. The crystals diffracted to 1.6 Å resolution using synchrotron radiation and belonged to the orthorhombic space group F222, with unit-cell parameters a = 72.1, b = 95.5, c = 146.1 Å . Data sets were collected from the native protein to 2.2 Å resolution using in-house equipment and to 1.6 Å resolution using synchrotron radiation and the three-dimensional structure was determined by the molecular-replacement method.
Introduction
Azo dyes are synthetic compounds that contain one or more azo bonds (-N N-). These dyes are extensively used in the textile, cosmetics, printing and food-colouring industries owing to their chemical stability and ease of synthesis (Meyer, 1981) . However, their strong stability constitutes a problem for the environment as these dyes are usually found in a chemically unchanged pollutant form even after wastewater treatment (Holme et al., 1984) . Nevertheless, despite their potentially toxic and carcinogenic properties (Alves de Lima et al., 2007) there are more than 2000 azo dyes and they make up around 50% of world dye production (Stolz, 2001; Alves de Lima et al., 2007) . This fact has led to a demand for more efficient technologies for the degradation of azo dyes. Degradation treatments based on chemical procedures are expensive, require a lot of energy and often yield hazardous byproducts. In contrast, biological degradation of azo dyes performed by microorganisms can be undertaken under mild conditions, avoiding these problems. Indeed, a variety of microorganisms have been shown to be able to decolourize a diverse range of azo dyes (Levine, 1991) . The dye-degrading enzymes that have been characterized to date are able to catalyze the reduction of azo dyes in the presence of NAD(P)H, transforming a number of them into colourless aromatic amines by cleaving the azo groups (Chen, 2006) . These enzymes are azobenzene reductases, commonly known as azoreductases, and contain a flavin mononucleotide (FMN or FAD) as a prosthetic group (Mueller & Miller, 1949) . Azoreductases have also been a subject of interest for the pharmaceutical industry. These enzymes, which are also expressed by the gastrointestinal microflora, have the ability to activate anti-inflammatory azo prodrugs such as 5-aminosalicylate-based compounds that are used to treat inflammatory bowel diseases (Peppercorn & Goldman, 1972) . These enzymes have been shown to reduce azo compounds via a ping-pong bi-bi mechanism that requires two cycles of NADPHdependent reduction of FMN to FMNH 2 , and references therein). In the first cycle the azo substrate is reduced to a hydrazine and in the second cycle the hydrazine is concomitantly reduced to two amines. Enzymes with azoreductase activity have been confirmed in many bacterial species and several crystallographic studies of enzymes from different origins have already been reported ( . With the aim of engineering an enzyme for biotechnological applications and to contribute to understanding the catalytic process that underlies the biodegradation of recalcitrant azo dyes, we have determined the three-dimensional structure of the FMNdependent NADPH azoreductase (PpAzoR) from Pseudomonas putida MET94, which was selected as a highly versatile bacterium for dye decolourization (Mendes et al., 2011) . In this study, we report the crystallization and preliminary X-ray diffraction analyses of PpAzoR crystals.
Experimental procedures 2.1. Cloning, expression and purification
The ppAzoR gene (accession No. NP_745010), which encodes a 203 amino-acid residue protein, was cloned into the expression vector pET-21a(+) (Novagen) and heterologously produced in Escherichia coli Tuner (DE3) (Novagen). The recombinant protein was purified in three chromatographic steps: briefly, a Q-Sepharose column followed by a Mono-Q 5/50 column (GE Healthcare Biosciences) and a Superdex 200 HR 10/30 column (GE Healthcare Biosciences) equilibrated with 20 mM Tris-HCl buffer pH 7.6 containing 0.2 M NaCl (Mendes et al., 2011) . Active fractions were pooled, concentrated and stored at 253 K until use. SDS-PAGE analysis revealed a molecular mass of $23 kDa (Fig. 1) , whereas size-exclusion chromatography yielded a native molecular mass of approximately 40 kDa, demonstrating that the recombinant PpAzoR1 forms a homodimer in solution, similar to previous observations for other flavin-dependent azoreductases (Chen et al., 2004; Ito et al., 2006; Liu et al., 2007; Nakanishi et al., 2001 ).
Crystallization
Crystallization screens were prepared in 96-well plates using the sitting-drop vapour-diffusion technique with a Cartesian robot. Each drop, consisting of 100 nl protein solution and 100 nl reservoir solution, was equilibrated against reservoir solution at 293 K. Once crystalline material had been identified (solution G1 from the NeXtal Classics Suite), a scale-up of the process was undertaken in 48-well plates with 3 ml drops (1.5 ml protein solution plus 1.5 ml reservoir solution) in order to obtain well diffracting crystals. PpAzoR crystals (Fig. 2 ) suitable for data collection were obtained after $10 d using protein solution at a concentration of 28 mg ml À1 (as measured by the Bradford assay with bovine serum albumin as standard) containing 2 mM FMN and reservoir solution consisting of 4% PEG 400, 2 M ammonium sulfate and 0.1 M HEPES pH 7.0 at 293 K.
X-ray analysis and structure solution
Crystals were cryoprotected with paraffin oil and flash-cooled under liquid nitrogen and initial crystal characterization was undertaken using in-house equipment (X8 PROTEUM diffractometer) at 110 K. The crystals diffracted to 2.2 Å resolution (the data statistics are listed in Table 1 ) and belonged to the orthorhombic space group F222, with unit-cell parameters a = 72.1, b = 95.5, c = 146.1 Å . The crystals contained one molecule per asymmetric unit, corresponding to a Matthews coefficient of 2.78 Å 3 Da À1 and a solvent content of 56% (Matthews, 1968) . This data set was processed and scaled with the programs SAINT and SADABS, respectively, as part of the Bruker AXS PROTEUM software suite and the data statistics were obtained with XPREP (Bruker AXS). The three-dimensional structure of PpAzoR was solved by molecular replacement with the program MOLREP (Vagin & Teplyakov, 2010) , using the azoreductase from E. coli (PDB code 2z9d; Ito et al., 2008) , which shows 46% sequence identity, as a search model. The correct solution given by the program MOLREP showed a score of 71.7% and an R factor of 43.7%, whereas the first noise solution showed a score and an R factor of 36.1% and 63.1%, respectively. A second data set ( Fig. 3) with higher resolution was then obtained on beamline ID14-4 at ESRF, Grenoble. These data were processed and scaled with the programs MOSFLM (Leslie, 2006) and SCALA (Evans, 2006) (the data-collection statistics are listed in Table 1 ) and are being used to refine the three-dimensional structure of PpAzoR.
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